Skip to main content

Advertisement

SpringerLink
Log in

Human Natural Killer Cells in Health and Disease

Biology and Therapeutic Potential

  • Review Article
  • Immunological Basis of Disease
  • Published:
Clinical Immunotherapeutics Aims and scope Submit manuscript

Summary

Natural killer (NK) cells, a small subset of peripheral blood lymphocytes, mediate a variety of functions that are important in human health and disease. In addition to their role in control of metastasis and infections, NK cells participate in immunoregulation, haematopoiesis, reproduction and neuroendocrine interactions. Defective or absent NK cell activity is associated with a spectrum of human diseases. Immunotherapy to augment or replace NK cell activity is becoming available. Therapeutic modification of NK cell activity is likely to become more widely used as our knowledge of the relevance of NK cells to health and disease states increases in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187–376

    Article  PubMed  CAS  Google Scholar 

  2. Hercend DT, Schmidt RE. Characteristics and uses of natural killer cells. Immunol Today 1988; 9: 291–3

    Article  PubMed  CAS  Google Scholar 

  3. Hata K, Zhang XR, Iwatsuki S, et al. Isolation, phenotyping and functional analysis of lymphocytes from human liver. Clin Immunol Immunopathol 1990; 56: 401–19

    Article  PubMed  CAS  Google Scholar 

  4. Lanier LL, Cwirla S, Federspiel N. Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen recepter beta chain genes. J Exp Med 1986; 163: 209–14

    Article  PubMed  CAS  Google Scholar 

  5. Vujanovic NL, Rabinowich H, Lee YJ, et al. Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic. Cell Immunol 1993; In press

    Google Scholar 

  6. Vitolo D, Vujanovic N, Rabinowich H, et al. Rapid interleukin-2 induced adherence of human natural killer (NK) cells: II. Expression of mRNA for cytokines and IL2 receptors in adherent NK cells. J Immunol 1993; 151: 1926–37

    PubMed  CAS  Google Scholar 

  7. Whiteside TL, Herberman RB. Extravasation of antitumor effector cells. Invasion Metastasis 1992; 12: 128–46

    PubMed  CAS  Google Scholar 

  8. Melder RJ, Walker E, Herberman RB, et al. Adhesion characteristics of human interleukin 2-activated natural killer cells. Cell Immunol 1991; 132: 177–92

    Article  PubMed  CAS  Google Scholar 

  9. Perussia B. Lymphokine-activated killer cells, natural killer cells and cytokines. Curr Opin Immunol 1991; 3: 49–55

    Article  PubMed  CAS  Google Scholar 

  10. Rabinowich H, Vitolo D, Altarac S, et al. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL2-activated natural killer cells. J Immunol 1992; 149: 340–9

    PubMed  CAS  Google Scholar 

  11. Shavit Y, Lewis JW, Terman W, et al. Opioid peptides mediate the suppressive effects of stress on natural killer cell cytotoxicity. Science 1984; 223: 188–90

    Article  PubMed  CAS  Google Scholar 

  12. Chang ZL, Whiteside TL, Herberman RB. Immunoregulatory role of in vitro differentiated macrophages on human natural killer (NK)-cell activity. Cell Immunol 1990; 125: 183–96

    Article  PubMed  CAS  Google Scholar 

  13. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990; 76: 2421–38

    PubMed  CAS  Google Scholar 

  14. Welsh RM. Regulation of virus infections by natural killer cells. Nat Immun Cell Growth Regul 1986; 5: 160–99

    Google Scholar 

  15. Skoner DP, Whiteside TL, Wilson JW, et al. Effect of rhinovirus 39 (RV-39) infection on cellular immune parameters in allergic and non-allergic subjects. J Allergy Clin Immunol 1993; In press

    Google Scholar 

  16. Djeu JY, Blanchard DK. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J Immunol 1987; 139: 2761–2

    PubMed  CAS  Google Scholar 

  17. Levy SM, Herberman RB, Simons A, et al. Persistently low natural killer cell activity in normal adults: immunological, hormonal and mood correlates. Nat Immun Cell Growth Regul 1989; 8: 173–86

    PubMed  CAS  Google Scholar 

  18. Whiteside TL, Herberman RB. The role of natural killer cells in human disease. Clin Immunol Immunopathol 1989; 53: 1–23

    Article  PubMed  CAS  Google Scholar 

  19. Barlozzari T, Reynolds CW, Herberman RB. In vivo role of natural killer cells: Involvement of large granular lymphocytes in the clearance of cells in anti-asialo GM-1 treated rats. J Immunol 1983; 131: 1024–7

    PubMed  CAS  Google Scholar 

  20. Strayer DR, Carter WA, Mayberry SD, et al. Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidence of cancer. Cancer Res 1984; 44: 370–4

    PubMed  CAS  Google Scholar 

  21. Purtilo DT, Strobach RS, Okano M, et al. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 1992; 67: 5–19

    PubMed  CAS  Google Scholar 

  22. Plaeger-Marshall S, Spina CA, Giorgi JV, et al. Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immunodeficiency syndrome (AIDS). J Clin Immunol 1987; 7: 16–23

    Article  PubMed  CAS  Google Scholar 

  23. Schantz SV, Brown BW, Lira E, et al. Evidence for the role of natural immunity in the control of metastatic spread of neck and head cancer. Cancer Immunol Immunother 1987; 141–5

    Google Scholar 

  24. Steinhauer EH, Doyle AT, Reed J, et al. Effective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacitiy in patients with advanced disease. J Immunol 1982; 129: 2255–9

    PubMed  CAS  Google Scholar 

  25. Cunningham-Rundles S, Flippa DA, Braun DW, et al. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. J Natl Cancer Inst 1981; 67: 585–90

    PubMed  CAS  Google Scholar 

  26. Zielinski CC, Tichatschek E, Muller C, et al. Association of increased lytic effector function with high estrogen receptor levels in tumor-bearing patients with breast cancer. Cancer 1989; 63: 1985–9

    Article  PubMed  CAS  Google Scholar 

  27. Lotzova E, Savary CA, Herberman RB. Impaired NK cell profile in leukemia patients. In: Lotzova E, Herberman RB, editors. Immunology of natural killer cells. Boca Raton, FL: CRC Press, 1987: 29–53

    Google Scholar 

  28. Nizoguchi H, O’Shea JJ, Longo DL, et al. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 1992; 258: 1795–1798

    Article  Google Scholar 

  29. Biron C, Byron KS, Sullivan J. Severe herpes virus infections in an adolescent without natural killer cells. N Engl J Med 1989; 320: 1731–5

    Article  PubMed  CAS  Google Scholar 

  30. Aoki R, Usuda T, Miyakoshi H, et al. Low NK syndrome (LNKS): clinical and immunologic features. Nat Immun Cell Growth Regul 1987; 6: 116–28

    PubMed  CAS  Google Scholar 

  31. Eby N, Grufferman S, Huang M, et al. Natural killer cell activity in the chronic fatigue-immune dysfunction syndrome. In: Ades EW, Lopez C, editors. Natural killer cells and host defense. Basel: Karger, 1988: 141–5

    Google Scholar 

  32. Chan WC, Link S, Mawle A, et al. Heterogeneity of large granular lymphocyte proliferations. Delineation of two major subtypes. Blood 1986; 68: 1142

    PubMed  CAS  Google Scholar 

  33. Imamura N, Kusunoki Y, Kawaha K, et al. Aggressive natural killer cell leukemia/lymphoma: report of 4 cases and review of the literature. Br J Hematol 1990; 75: 49

    Article  CAS  Google Scholar 

  34. Hata K, Van Thiel DH, Herberman RB, et al. Natural killer activity of human liver-derived lymphocytes in various hepatic diseases. Hepatology 1991; 14: 495–503

    Article  PubMed  CAS  Google Scholar 

  35. Heiskala MK, Stenman UH, Koivunen E, et al. Characteristics of soluble tumor-derived proteins that inhibit natural killer activity. Scand J Immunol 1988; 28: 19–27

    Article  PubMed  CAS  Google Scholar 

  36. Vitolo D, Letessier EM, Johnson JT, et al. Immunologic effector cells in head and neck cancer. J Natl Cancer Inst Monogr 1992; 203–208

    Google Scholar 

  37. Caligiuri MA, Murray C, Robertson MJ, et al. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J Clin Invest 1993; 91: 123–32

    Article  PubMed  CAS  Google Scholar 

  38. Whiteside TL, Herberman RB. Characteristics of natural killer cells and lymphokine-activated killer cells: their role in the biology and treatment of human cancer. Immunol Allergy Clin N Am 1990; 10: 663–704

    Google Scholar 

  39. Hercend T, Farace F, Baume D, et al. Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin 2: a feasibility trial in metastatic renal cell carcinoma. J Biol Resp Mod 1990; 9: 546–55

    CAS  Google Scholar 

  40. Rosenberg SA, Lotze MT, Yang JC, et al. Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst 1993; 85: 622–32

    Article  PubMed  CAS  Google Scholar 

  41. Ortaldo JR, Mason A, Overton R. Lymphokine-activated killer cells: analysis of progenitors and effectors. J Exp Med 1986; 164: 1193–205

    Article  PubMed  CAS  Google Scholar 

  42. Yasumura S, Weidmann E, Hirabayashi H, et al. HLA restriction and T-cell receptor Vβ gene expression of cytotoxic T lymphocytes reactive with human squamous cell carcinoma of the head and neck. Int J Cancer 1993; submitted

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

    Theresa L. Whiteside & Ronald B. Herberman

  2. Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

    Theresa L. Whiteside

  3. Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

    Ronald B. Herberman

Authors
  1. Theresa L. Whiteside
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronald B. Herberman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Whiteside, T.L., Herberman, R.B. Human Natural Killer Cells in Health and Disease. Clin. Immunother. 1, 56–66 (1994). https://doi.org/10.1007/BF03258491

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03258491

Keywords

Search

Navigation